GSK-NAIA1002

Study Sponsor: GSK

Study Title

A Study to Investigate the Effect of Intranasal GG167 Initiated at Various Intervals Post Inoculation on Infection in Healthy Volunteers when Experimentally Inoculated with Influenza A/Texas/91 (H1N1) Virus

Medicine or Vaccine (generic name)

zanamivir

Sponsor Identification Number

NAIA1002

Trial Registry Identification Number(#'s)

N/A

Medical Condition

Influenza, Human

Phase

Phase 1

Link to GSK Study Register

http://www.gsk-clinicalstudyregister.com/study/NAIA1002

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report

Additional information about the data and documents available for this study

An analysis-ready dataset, an annotated case report form, and a reporting and analysis plan are not available for this study. A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.

Date Added to this Site

May 2015